Clinical Trial Update: Cell Therapy in Severe Chronic Ischemic Heart Disease [Phase 3]

View source ↗

Summary

A Phase 3 trial update for a cell therapy in severe chronic ischemic heart disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Angina Pectoris
• Coronary Artery Disease
• Ischemic Heart Disease

Snippet

Sponsor: Ministry of Health, Brazil | Conditions: Chronic Ischemic Heart Disease, Coronary Artery Disease | Phase 3 | Status: COMPLETED